MetaCap

ADARx Pharmaceuticals (ADRX) News

NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.79-1.37 (-9.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADRX news summary

We found 3 recent headlines mentioning ADARx Pharmaceuticals (ADRX): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. ADRX is making an outsized move today, down 9.68% at $12.79, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "ADARx Advances Agazisiran, Onvuzosiran Programs; Key Clinical Readouts Set For 2027", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ADARx Pharmaceuticals headlines

Stocks mentioned alongside ADRX

Compare ADRX